Sustained formulation for prevention or treatment of autoimmune disease containing naltrexone and method using the same
US11730731B2 · kind B2 · utility
0Cited by
0References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 22, 2022 |
| Grant date | Aug 22, 2023 |
| Priority date | — |
| Expiry date | Jul 22, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides a sustained formulation for prevention or treatment of autoimmune disease, comprising microparticles comprising naltrexone or pharmaceutically acceptable salts thereof, and biodegradable polymers, and a method using the same. Accordingly, it may be used to prevent or treat autoimmune diseases for a prolonged period of time with a single administration.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.